RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ANTINORI A
Collezione ASL Città di Torino

Items : 24

Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians' and nurses' points of view. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2024 Oct 1;79(10):2662-2667. doi: 10.1093/jac/dkae273.

2024
ASL Città di Torino

Antinori A; d'Arminio Monforte A; Torti C; Cernuschi M; Guastavigna M; Mazzitelli M; Compagno M; Bini T; Carraro A; Muccini C; De Benedittis S; Mastrorosa I; Tavelli A; Cingolani A;

Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study. in Brain : a journal of neurology / Brain. 2024 Nov 4;147(11):3742-3750. doi: 10.1093/brain/awae271.

2024
ASL Città di Torino

Gulminetti R; Ripamonti D; Antinori A; Muscatello A; Gabrieli A; Bruzzesi E; Rusconi S; Marchetti G; Bernasconi D; Trunfio M; Cinque P; Cusato J; Antonucci M; Calcagno A; Nozza S;

Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis - results from the ICONA cohort in Italy, 2009-2022. in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases / Int J Infect Dis. 2024 May;142:106995. doi: 10.1016/j.ijid.2024.106995. Epub 2024 Mar 6.

2024
ASL Città di Torino

Mondi A; Cozzi-Lepri A; Mussini C; d'Arminio Monforte A; Antinori A; Girardi E; Marchetti G; Bandera A; De Girolamo G; Saracino A; Gori A; Pinnetti C; Orofino G; Giacomelli A; Cingolani A; Tavelli A;

The presence of resistance-associated mutations in reverse transcriptase gene is associated with cerebrospinal fluid HIV-1 escape: A multicentric retrospective analysis. in Journal of medical virology / J Med Virol. 2023 Apr;95(4):e28704. doi: 10.1002/jmv.28704.

2023
ASL Città di Torino

Antinori A; Bonora S; Ghisetti V; D'Arminio Monforte A; Focà E; Vera JH; D'Ettorre G; Arsuffi S; Celani L; Bai F; Pinnetti C; Trunfio M; Calcagno A;

Effectiveness and safety of darunavir/cobicistat/emtricitabine/tenofovir alafenamide therapy in an observational Italian cohort: The DIAMANTE study in Future Virology

2023
ASL Città di Torino

Antinori A; Vergori A; Ripamonti D; Valenti D; Rizzardini G; Cossu MV; Rusconi S; Esposito V; Cascio A; Orofino G; Andreoni M; Manzillo E; Castagna A; Mancusi D; Termini R; Portaro M; Uglietti A;

Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz. in Nutrients / Nutrients. 2021 Oct 12;13(10):3571. doi: 10.3390/nu13103571.

2021
ASL Città di Torino

Calcagno A; Tempestilli M; Cusato J; Vergori A; Piselli P; Antonucci M; Avataneo V; Palermiti A; Notari S; Antinori A; Di Perri G; Agrati C; D'Avolio A;

Pharmacokinetics of bictegravir, emtricitabine and tenofovir alafenamide in a gastrectomized patient with HIV. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2021 Nov 12;76(12):3320-3322. doi: 10.1093/jac/dkab319.

2021
ASL Città di Torino

D'Avolio A; Tempestilli M; De Nicolò A; Agrati C; Antinori A; Cicalini S;

Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort. in HIV medicine / HIV Med. 2020 Sep;21(8):523-535. doi: 10.1111/hiv.12885. Epub 2020 Jun 24.

2020
ASL Città di Torino

Calcagno A; Pinnetti C; Mastrangelo A; Bruzzesi E; De Benedetto I; Nozza S; Fabbiani M; Taramasso L; Ferrara M; Bozzi G; Focà E; Quiros-Roldan E; Ripamonti D; Campus M; Celesia BM; Torti C; Cosco L; Di Biagio A; Rusconi S; Marchetti G; Mussini C; Gulminetti R; Cingolani A; d'Ettorre G; Madeddu G; Franco A; Orofino G; Squillace N; Muscatello A; et alii...

Beyond Italian guidelines in the management of HIV-positive patient. in Le infezioni in medicina / Infez Med. 2020 Nov 1;28(4):587-596.

2020
ASL Città di Torino

Mussini C; Gori A; Galli M; D'Arminio Monforte A; Di Perri G; Castagna A; Antinori A; Andreoni M; Perno CF;

Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: A multicentre study promoted by the Italian Society of Infectious and Tropical Diseases. in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases / Int J Infect Dis. 2020 Mar;92:62-68. doi: 10.1016/j.ijid.2019.12.031. Epub 2019 Dec 27.

2020
ASL Città di Torino

Cuzzi G; Compagno M; Cimaglia C; Petruccioli E; Navarra A; Goletti D; De Carli G; Fondaco L; Franzetti F; Giannetti A; Gori A; Lapadula G; Lichtner M; Mastroianni CM; Mazzotta V; Orchi N; Pavone P; Piacentini D; Pirriatore V; Pontali E; Sarmati L; Spolti A; Tacconelli E; Galli M; Antinori A; Calcagno A; Girardi E;

Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression. in The patient / Patient. 2020 Jun;13(3):375-387. doi: 10.1007/s40271-020-00413-y.

2020
ASL Città di Torino

Squillace N; Di Cristo V; Mancusi D; Scerbo P; Gori A; Rucci F; Termini R; Uglietti A; Rossetti B; Pontali E; D'Ettore G; Madeddu G; Locatelli ME; Ferrara S; Aprea L; Orofino G; Valenti D; Castagna A; Cattelan A; Focà E; Sterrantino G; Menzaghi B; Antinori A; Cossu MV;

Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" Study. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):290-294. doi: 10.1097/QAI.0000000000002331.

2020
ASL Città di Torino

Sterrantino G; Menzaghi B; Cossu MV; Vergori A; Antinori A; Gori A; Rusconi S; Cattelan AM; Castelli F; Gianotti N; Orofino G; Ripamonti D; Savinelli S; Manzillo E; Santantonio TA; Celesia BM; Cauda R; Maserati R; d'Arminio Monforte A; Stingone C; Bonora S; Uglietti A; Termini R; Rucci F; Mancusi D;

Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression. in The patient / Patient. 2020 Aug;13(4):469-470. doi: 10.1007/s40271-020-00425-8.

2020
ASL Città di Torino

Gori A; Rucci F; Uglietti A; Termini R; Rossetti B; Scerbo P; Pontali E; Madeddu G; Locatelli ME; Ferrara S; Aprea L; D'Ettore G; Valenti D; Orofino G; Castagna A; Focà E; Cattelan A; Di Cristo V; Squillace N; Sterrantino G; Cossu MV; Menzaghi B; Antinori A; Mancusi D;

Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective Study. in Pathogens & immunity / Pathog Immun. 2020 Feb 24;5(1):8-33. doi: 10.20411/pai.v5i1.341. eCollection 2020.

2020
ASL Città di Torino

Mussini C; Gulminetti R; Cingolani A; D'ettorre G; Madeddu G; Franco A; Orofino G; Squillace N; Muscatello A; Bandera A; Gori A; Tambussi G; Marchetti G; Rusconi S; Cosco L; Di Biagio A; Torti C; Maurizio Celesia B; Pinnetti C; Calcagno A; Ferrara M; Campus M; Ripamonti D; Quiros-Roldan E; Focà E; Antinori A; Dell'acqua R; Ripa M; De Benedetto I; et alii...

Durability of F/TAF in a large cohort of PLWH seen for care in Italy in Journal of the International AIDS Society

2020
ASL Città di Torino

Antinori A; Gentile I; Loredana S; Cicalini S; D'Arminio Monforte A; Moioli M; Guaraldi G; Orofino G; Vergori A; Cozzi Lepri A; Gianotti N; Calcagno A;

Impact of genotypic susceptibility score on cART outcomes during primary HIV infection. in Journal of medical virology / J Med Virol. 2019 Oct;91(10):1891-1895. doi: 10.1002/jmv.25517. Epub 2019 Jun 27.

2019
ASL Città di Torino

Giacomelli A; Fabbiani M; De Benedetto I; Nozza S; Focà E; Celesia BM; Marchetti G; Mussini C; Antinori A; d'Ettorre G; Madeddu G; Bandera A; Muscatello A; Rusconi S;

Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort. in Journal of the International AIDS Society / J Int AIDS Soc. 2019 Jan;22(1):e25227. doi: 10.1002/jia2.25227.

2019
ASL Città di Torino

Mondi A; Cozzi-Lepri A; Tavelli A; Rusconi S; Vichi F; Ceccherini-Silberstein F; Calcagno A; De Luca A; Maggiolo F; Marchetti G; Antinori A; d'Arminio Monforte A;

Development and validation of an HPLC-UV method for quantification of elvitegravir and two other new antiretrovirals, dolutegravir and rilpivirine, in the plasma of HIV-positive patients. in Biomedical chromatography : BMC / Biomed Chromatogr. 2018 May 4:e4274. doi: 10.1002/bmc.4274.

2018
ASL Città di Torino

Tempestilli M; Ammassari A; D'Avolio A; Cicalini S; Gallo AL; Fazio S; Antinori A; Pucillo LP;

Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Jul 1;73(7):1955-1964. doi: 10.1093/jac/dky123.

2018
ASL Città di Torino

Fabbiani M; Gagliardini R; Ciccarelli N; Quiros Roldan E; Latini A; d'Ettorre G; Antinori A; Castagna A; Orofino G; Francisci D; Chinello P; Madeddu G; Grima P; Rusconi S; Del Pin B; Lombardi F; D'Avino A; Focà E; Colafigli M; Cauda R; Di Giambenedetto S; De Luca A;

Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessment. in The new microbiologica / New Microbiol. 2018 Apr;41(2):112-117.

2018
ASL Città di Torino
AOU Città della Salute di Torino

Acone B; Calza L; Rizzardini G; Quirino T; Viale P; Perno CF; Lazzarin A; Mussini C; Galli M; Gori A; Di Perri G; Di Biagio A; Cinque P; D'Arminio Monforte A; Chirianni A; Antinori A; Angarano G; Borderi M; Andreoni M;

Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients. in PloS one / PLoS One. 2018 Feb 20;13(2):e0192627. doi: 10.1371/journal.pone.0192627. eCollection 2018.

2018
ASL Città di Torino
AOU Città della Salute di Torino

Segala D; Teti E; Taramasso L; Di Biagio A; Bovis F; Nicolini LA; Antinori A; Milazzo L; Chirianni A; Vullo V; Parruti G; Giacometti A; Cacopardo B; Boffa N; Gori A; Spinetti A; Puoti M; Pasquazzi C; Di Perri G; Mastroianni C; Bruno R; Borghi V; Montagnani F; Cattelan A; Hasson H; Taliani G; D'Arminio Monforte A; Bigoni S; Saracino A; et alii...

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2017 Mar 1;64(5):680-683. doi: 10.1093/cid/ciw846. Epub 2016 Dec 22.

2017
ASL Città di Torino
AOU Città della Salute di Torino

Massimo A; Teti E; Pasquazzi C; Pennica A; Chirianni A; Vullo V; Parruti G; Giacometti A; Bruno C; Boffa N; Gori A; Spinetti A; Puoti M; Bigoni S; Di Perri G; Mastroianni CM; Monforte AD; Taliani G; Hasson H; Cattelan A; De Luca A; Borghi V; Saracino A; Bruno R; Di Biagio A; Rizzardini G; Sollima S; Milazzoi L; Antinori A; et alii...

Treatment simplification to atazanavir/ritonavir?+?lamivudine versus maintenance of atazanavir/ritonavir?+?two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M). in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Apr 1;72(4):1163-1171. doi: 10.1093/jac/dkw557.

2017
ASL Città di Torino

Di Giambenedetto S; Fabbiani M; Quiros Roldan E; Latini A; D'Ettorre G; Antinori A; Castagna A; Orofino G; Francisci D; Chinello P; Madeddu G; Grima P; Rusconi S; Di Pietro M; Mondi A; Ciccarelli N; Borghetti A; Focà E; Colafigli M; De Luca A; Cauda R;

Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial. in PloS one / PLoS One. 2017 Nov 21;12(11):e0187393. doi: 10.1371/journal.pone.0187393. eCollection 2017.

2017
ASL Città di Torino

Rossetti B; Gagliardini R; Meini G; Sterrantino G; Colangeli V; Re MC; Latini A; Colafigli M; Vignale F; Rusconi S; Micheli V; Di Biagio A; Orofino G; Ghisetti V; Fantauzzi A; Vullo V; Grima P; Francisci D; Mastroianni C; Antinori A; Trezzi M; Lisi L; Navarra P; Canovari B; D'Arminio Monforte A; Lamonica S; D'Avino A; Zazzi M; Di Giambenedetto S; et alii...